Vertex Pharmaceuticals Inc. buy Truist Financial Co.
Start price
23.12.24
/
50%
€382.35
Target price
23.12.25
€442.38
Performance (%)
-11.69%
Price
22.08.25
€337.65
Summary
This prediction is currently active. The prediction for Vertex Pharmaceuticals Inc. disappoints with a performance of -11.69%. This prediction currently runs until 23.12.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 0.581% | 0.581% |
| iShares Core DAX® | -0.099% | 1.027% |
| iShares Nasdaq 100 | -1.085% | 2.134% |
| iShares Nikkei 225® | -0.835% | 8.556% |
| iShares S&P 500 | 0.099% | 2.881% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at Truist Financial Co. from $550.00 to $460.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€340.25
05.08.25
05.08.25
€423.90
05.08.26
05.08.26
-0.76%
22.08.25
22.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€442.55
11.02.25
11.02.25
€502.37
11.02.26
11.02.26
-23.70%
22.08.25
22.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€432.30
05.08.24
05.08.24
€500.78
05.08.25
05.08.25
-24.98%
06.08.25
06.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€400.85
31.01.24
31.01.24
€470.15
31.01.25
31.01.25
10.07%
01.02.25
01.02.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€332.85
04.10.23
04.10.23
€434.43
04.10.24
04.10.24
24.34%
05.10.24
05.10.24